Skip to main content

What the FDA labels say about taking them together

Enalapril and tenapanor

Tenapanor's FDA label of June 27, 2025 names enalapril in its drug interactions section; the enalapril labels PlainMeds reads (2) do not name tenapanor. The tenapanor label: “DRUG INTERACTIONS OATP2B1 Substrates: Potential for reduced exposure of the concomitant drug (e.g., enalapril).”

Check it at the source: the enalapril FDA label on DailyMed (effective January 23, 2026, Bausch Health US LLC); the tenapanor FDA label on DailyMed (effective June 27, 2025, Ardelyx, Inc.).

What does the enalapril label say about tenapanor?

Enalapril's label (effective January 23, 2026) and its 1 other brand-application label do not name tenapanor in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Vasotec), Bausch Health US LLC, effective January 23, 2026 (SPL set 39631f1f-5d19-43c1-b504-bf56d991ed97), via openFDA; the full label on DailyMed

What does the tenapanor label say about enalapril?

Tenapanor label, drug interactions

DRUG INTERACTIONS OATP2B1 Substrates: Potential for reduced exposure of the concomitant drug (e.g., enalapril).

Source: FDA drug label (XPHOZAH 10 mg), Ardelyx, Inc., effective June 27, 2025 (SPL set c57e279c-0f1b-4238-81b7-4e0dc0cc60c5), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

28Enalapril generic labelers
0Tenapanor generic labelers
EnalaprilTenapanor
Labeled forHigh blood pressure, Heart failureIrritable bowel syndrome, Constipation
Boxed warningYesNo
Pharmacy cost (NADAC)$0.0664 per tablet 10 mg tablet$32.54 per tablet 50 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?